Vise Technologies’s ICU Medical ICUI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-2,392
Closed -$287K 1499
2025
Q3
$287K Sell
2,392
-585
-20% -$74.1K 0.01% 912
2025
Q2
$393K Buy
+2,977
New +$404K 0.02% 734
2024
Q4
$411K Buy
2,649
+176
+7% +$29.8K 0.03% 495
2024
Q3
$451K Buy
+2,473
New +$366K 0.06% 322
2023
Q3
Sell
-1,315
Closed -$234K 345
2023
Q2
$234K Sell
1,315
-1,704
-56% -$313K 0.06% 293
2023
Q1
$498K Buy
3,019
+1,247
+70% +$215K 0.13% 165
2022
Q4
$279K Sell
1,772
-126
-7% -$19.2K 0.09% 248
2022
Q3
$286K Buy
1,898
+594
+46% +$98.8K 0.11% 215
2022
Q2
$214K Buy
+1,304
New +$251K 0.08% 267

Other funds holding ICUI

Vise Technologies's ICUI Position: Q4 2025 in Review

Vise Technologies sold out of ICU Medical (ICUI) in Q4 2025, closing a stake of 2,392 shares — an estimated $287K sold.

Vise Technologies first reported a position in ICUI in Q2 2022 and held it in 9 quarters. The position peaked at $498K in Q1 2023. 291 funds tracked by Wall St. Rank hold ICUI as of Q4 2025.

  • Vise Technologies reported no remaining ICU Medical position as of Q4 2025 after selling out during the quarter.
  • Vise Technologies sold 2,392 ICU Medical shares in Q4 2025, an estimated $287K.
  • Vise Technologies first reported a position in ICU Medical in Q2 2022 and held it in 9 quarters.
  • Vise Technologies's ICU Medical position peaked at $498K in Q1 2023.
  • 291 funds tracked by Wall St. Rank held ICU Medical as of Q4 2025.

Based on Vise Technologies's 13F filing for Q4 2025, filed 11 Feb 2026.